Skip to main content
Fig. 7 | BMC Cancer

Fig. 7

From: Expression of the cereblon binding protein argonaute 2 plays an important role for multiple myeloma cell growth and survival

Fig. 7

Treatment of MM cells with lenalidomide altered steady-state levels of miRNAs. Total RNAs were isolated at day 3 or day 5 post 10 μM lenalidomide treatment and the steady-state levels of miRNAs were analyzed with microRNA array kit. a Comparison of the steady-state levels of miRNAs between My5.LV and My5.LV treated with 10 μM lenalidomide for 3 days; b between My5.LV and My5.LV treated with 10 μM lenalidomide for 5 days; c between My5.CRBN and My5.CRBN treated with 10 μM lenalidomide for 3 days; d between My5.CRBN and My5.CRBN treated with 10 μM lenalidomide for 5 days

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us